INVOLVEMENT OF METABOTROPIC GLUTAMATE RECEPTOR MGLU5 IN PUDENDAL INHIBITION OF BLADDER OVERACTIVITY IN CATS

被引：0
|
作者：
Larson, Jeffrey
Ogagan, P. Dafe
Wang, Jicheng
Shen, Bing
Roppolo, James
Tai, Changfeng
de Groat, William C.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.310
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
253
引用
收藏
页码：E102 / E103
页数：2
相关论文
共 50 条
  • [41] Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists
    Chua, PC
    Nagasawa, JY
    Bleicher, LS
    Munoz, B
    Schweiger, EJ
    Tehrani, L
    Anderson, JJ
    Cramer, M
    Chung, J
    Green, MD
    King, CD
    Reyes-Manalo, G
    Cosford, NDP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4589 - 4593
  • [42] Antagonism of Group I metabotropic glutamate receptor and sensory responses by novel selective mGlu5 and mGlu1 antagonists in the thalamus
    Salt, TE
    Binns, KE
    Turner, JP
    NEUROPHARMACOLOGY, 1999, 38 (10) : A38 - A38
  • [43] Effects of Duloxetine and WAY100635 on Pudendal Inhibition of Bladder Overactivity in Cats
    Reese, Jeremy
    Xiao, Zhiying
    Schwen, Zeyad
    Matsuta, Yosuke
    Shen, Bing
    Wang, Jicheng
    Roppolo, James R.
    de Groat, William C.
    Tai, Changfeng
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 349 (03): : 402 - 407
  • [44] Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat
    Cavas, Maria
    Scesa, Gianluigi
    Francisco Navarro, Jose
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 18 - 25
  • [45] Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system
    Di Menna, Luisa
    Joffe, Max E.
    Iacovelli, Luisa
    Orlando, Rosamaria
    Lindsley, Craig W.
    Mairesse, Jerome
    Gressens, Pierre
    Cannella, Milena
    Caraci, Filippo
    Copani, Agata
    Bruno, Valeria
    Battaglia, Giuseppe
    Conn, P. Jeffrey
    Nicoletti, Ferdinando
    NEUROPHARMACOLOGY, 2018, 128 : 301 - 313
  • [46] Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity
    Battaglia, G
    Fornai, F
    Busceti, CL
    Aloisi, G
    Cerrito, F
    De Blasi, A
    Melchiorri, D
    Nicoletti, F
    JOURNAL OF NEUROSCIENCE, 2002, 22 (06): : 2135 - 2141
  • [47] Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling
    Nishi, A
    Liu, F
    Matsuyama, S
    Hamada, M
    Higashi, H
    Nairn, AC
    Greengard, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) : 1322 - 1327
  • [48] Metabotropic glutamate 5 (mGlu5) receptors may represent viable therapeutic targets for the treatment of alcoholism
    Rorick-Kehn, L. M.
    McKinzie, D. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 131A - 131A
  • [49] Modulation of metabotropic glutamate mGlu5 receptor and its signaling pathway in human brain of Alzheimer's disease and Schizophrenia
    Diaz-Sanchez, S.
    Barrachina, M.
    Ferrer, I.
    Albasanz, J. L.
    Martin, M.
    FEBS JOURNAL, 2015, 282 : 180 - 180
  • [50] Mouse hepatocytes lacking mGlu5 metabotropic glutamate receptors are less sensitive to hypoxic damage
    Storto, M
    Battaglia, G
    Gradini, R
    Bruno, V
    Nicoletti, F
    Vairetti, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 497 (01) : 25 - 27
12345